Penny stock TTOO faces downward pressure amid concerns of reverse stock split

Fundamental Stock Analysis

T2 Biosystems, Inc. (Ticker: TTOO), which is listed on NASDAQ, is observed to be a high-risk, high-reward penny stock trading under $1. Trading at its last close price of $0.335 on August 28, 2023, the change in its price was -0.03 or -8.84%. Despite this decrease, TTOO's price is still higher than its 50-day moving average of $0.207, suggesting some recent upward momentum, yet significantly lower than its 200-day moving average of $0.748, which could indicate a longer-term downturn in the stock's performance.

The company's market capitalization is just shy of the small-cap threshold at $111.75 million. The latest earnings per share (EPS) of TTOO stands at $-2.13, indicating a net loss, which gives the stock a negative PE ratio of -0.16. The negative earnings may raise concerns about the company's overall profitability.

With an average volume of 113.62 million shares, the company's recent trading volume on August 28, 2023, was slightly lower at 80.93 million shares. As for pending corporate actions, an upcoming earnings announcement is slated for November 8, 2023, and the company is seeking approval for a reverse stock split in a range between 1-for-50 and 1-for-150 on its annual meeting of stockholders on September 12, 2023. A successful vote for a reverse stock split could increase the value of the individual shares.

Technical Stock Analysis

TTOO's Relative Strength Index (RSI) of 52 suggests that the stock is neither in an overbought nor oversold zone, indicating a neutral position. However, although the stock price is higher than its 50-day moving average, the recent significant pullback from this month's high of $0.696 to $0.335 is noteworthy.

Moreover, the potential resistance identified at $0.3425 is not much higher than its last close of $0.335, with the immediate support level seen at $0.3271. This narrow range implies limited near-term upward potential or high sensitivity to trading volume and news-driven events. Furthermore, the high Average True Range (ATR) value of 27.48 is suggestive of high volatility, making the stock's price movements unpredictable.

The MACD (3-month) of 0.141713 also indicates that the short-term trend is bearish as the MACD line (short-term moving average) is below the signal line (long-term moving average).

Stock Prediction and Final Evaluation

Based on the presented data, T2 Biosystems' stock price might experience more downward pressure in the next trading day, and probably in the upcoming week. The announcement for a potential reverse stock split implies that management is concerned about the low stock price, and this could further dip investor sentiment. The recent trend appears to be less favorable for short-term traders with its high volatility and negative momentum confirmed by MACD.

However, looking at the bigger picture, considering the company's inclusion in the list of best penny stocks to buy now and its potential to rebound as shared in some recent news, it could present a trading opportunity for high-risk tolerance investors.

Considering all these factors, TTOO can be categorized as a "Hold" for now. The upcoming earnings report and the stockholders' meeting could provide further insights into the direction of the stock for investors. Investors with a high risk-tolerance level might want to monitor this stock closely for any potential buying opportunities. However, any investment decision should be made with consideration for individual investment goals, risk appetite, and market conditions, along with comprehensive research and professional advice.